Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
type: MedicalStudy
description: Phase II High Pulse Dose Clinical Trial of Orally Administered ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2008-10
end date: 2010-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00792506
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Italfarmaco
study subject: Multiple Myeloma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Multiple Myeloma

AI Analytics
type: Organization